OptimizeRx forecasts $95M-$100M 2026 revenue
OptimizeRx Corporation expects to generate $95M-$100M in revenue for Q1 2026.
The company also anticipates maintaining $21M-$25M in adjusted EBITDA.
This forecast comes amid ongoing softness in contracted revenue, according to management.